Prognostic Significance of Ultrasound Myocardial Tissue Characterization in Patients With Cardiac Amyloidosis

Background—Cycle-dependent variation of myocardial integrated backscatter (CV-IB) is an objective measurement that may detect myocardial abnormalities. However, no data exist about the prognostic value of CV-IB in primary cardiac amyloidosis. Methods and Results—We prospectively examined 208 consecutive biopsy-proven patients with primary amyloidosis. The magnitude of CV-IB was analyzed at the interventricular septum and left ventricular (LV) posterior wall and its prognostic value was compared with standard Doppler measurements with to the Tei index (isovolumic contraction time plus isovolumic relaxation time divided by ejection time). One hundred thirty-three patients had cardiac involvement (mean LV thickness > 12 mm). Forty-one patients (20%) (32 cardiac deaths) died during a mean follow-up of period of 307±156 days. Univariate analysis showed that the CV-IB at the LV posterior wall was the best predictor of cardiac death (P <0.0001) and all-cause death (P < 0.0001). The Tei index did not identify patients at risk of death. Multivariate analysis showed that CV-IB at the LV posterior wall was the only independent predictor of both cardiac and overall deaths. Conclusions—Among patients with cardiac amyloidosis, CV-IB at the LV posterior wall is a powerful predictor of clinical outcome and is superior to standard echocardiographic/Doppler flow indexes.

[1]  R. Falk,et al.  Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. , 1998, Blood.

[2]  Brent K. Hoffmeister,et al.  Detection of Unique Transmural Architecture of Human Idiopathic Cardiomyopathy by Ultrasonic Tissue Characterization , 1992, Circulation.

[3]  A. Weyman,et al.  Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. , 1987, Journal of the American College of Cardiology.

[4]  L Landini,et al.  Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. , 1995, Journal of the American College of Cardiology.

[5]  L. Landini,et al.  Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. , 1991, Journal of the American College of Cardiology.

[6]  J. Seward,et al.  M‐mode and Two‐dimensional Echocardiographic Features in Cardiac Amyloidosis , 1981, Circulation.

[7]  C. Angermann,et al.  Recognition of acute cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients. Comparison with conventional echocardiography. , 1997, Circulation.

[8]  E. Arbustini,et al.  Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[9]  J. Seward,et al.  Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis: A Doppler Echocardiography Study , 1991, Circulation.

[10]  J. G. Miller,et al.  Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. , 1992, Journal of the American College of Cardiology.

[11]  J. Seward,et al.  Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. , 1985, Journal of the American College of Cardiology.

[12]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[13]  I Schnittger,et al.  Ultrasonic tissue characterization with a real time integrated backscatter imaging system in normal and aging human hearts. , 1989, Journal of the American College of Cardiology.

[14]  Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis , 1991 .

[15]  R. Bonow,et al.  Alterations in ultrasonic backscatter during exercise-induced myocardial ischemia in humans. , 1995, Circulation.

[16]  J G Miller,et al.  Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiers. , 1995, Journal of the American College of Cardiology.

[17]  J. Seward,et al.  Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. , 1989, Journal of the American College of Cardiology.

[18]  P Colonna,et al.  Effects of acute myocardial ischemia on intramyocardial contraction heterogeneity: A study performed with ultrasound integrated backscatter during transesophageal atrial pacing. , 1999, Circulation.

[19]  W. O’Brien,et al.  Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness. , 1995, Circulation.

[20]  R. Popp,et al.  Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. , 1989, Circulation.

[21]  L S Wann,et al.  Intramyocardial variability in integrated backscatter: effects of coronary occlusion and reperfusion. , 1987, Circulation.

[22]  A J Tajik,et al.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. , 1996, Journal of the American College of Cardiology.

[23]  J. Seward,et al.  Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. , 1990, Journal of the American College of Cardiology.

[24]  R. Falk,et al.  An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis , 2001, Bone Marrow Transplantation.

[25]  M. Hori,et al.  Analysis of transmural trend of myocardial integrated ultrasound backscatter for differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. , 1994, Journal of the American College of Cardiology.

[26]  J. G. Miller,et al.  A relationship between ultrasonic integrated backscatter and myocardial contractile function. , 1985, The Journal of clinical investigation.

[27]  J. G. Miller,et al.  Three-dimensional characterization of human ventricular myofiber architecture by ultrasonic backscatter. , 1991, The Journal of clinical investigation.

[28]  J. G. Miller,et al.  Ultrasonic characterization of myocardium. , 1985, Progress in cardiovascular diseases.

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[30]  I Schnittger,et al.  Serial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection. , 1990, Circulation.

[31]  L. Wann,et al.  Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. , 1988, Circulation.

[32]  R. Falk,et al.  Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. , 1987, The American journal of cardiology.

[33]  J. G. Miller,et al.  Quantitative ultrasonic tissue characterization with real-time integrated backscatter imaging in normal human subjects and in patients with dilated cardiomyopathy. , 1987, Circulation.